Glossary Updates16 new terms added to the glossaries · November 12, 2026, 21:23 CET
AI TechDocKnowledge

Glossary · EU medical devices: MDR

Benefit-risk determination (MDR)

Also known as: Benefit-risk analysis (MDR), Benefit-risk ratio, Benefit-risk balance

German: Nutzen-Risiko-Abwägung

Under the EU Medical Device Regulation (EU) 2017/745, the benefit-risk determination is the analysis of all assessments of benefit and risk of possible relevance for the use of the device for the intended purpose, when used in accordance with the intended purpose given by the manufacturer. It has to remain acceptable over the device's lifecycle.

  • EU
  • MDR
  • IVDR
  • Technical documentation

In one sentence

MDR benefit-risk determination (Art. 2(24)): weighing all benefits and risks of a device used as intended; it must stay acceptable over the lifecycle.

Example

For an implantable cardiac monitor, the manufacturer weighs earlier detection of arrhythmias (clinical benefit) against infection and migration risks; PMCF data on infection rates later update the determination in the clinical evaluation report.

Explained in context

This term is a station of a mini course

  • The medical-device evidence chain: from intended purpose to post-market evidenceStation: Risk management fileStart the course

Context cards connect this term with others to answer one question. Also in British English and German.

How it applies

  • Annex I Section 1: Risks must be acceptable when weighed against the benefits to the patient; GSPR 8 asks that known and foreseeable risks and side effects are minimized and acceptable against the evaluated benefits.
  • Where it sits: Annex II Section 5 asks for the benefit-risk analysis and risk management in the technical documentation. The clinical evaluation provides the clinical benefits, the risk management file the residual risks.
  • Lifecycle: Post-market surveillance and PMCF data update the determination; the PSUR reports its conclusions for class IIa and higher.
  • Technical documentation: State the determination once, with its date and the evidence it rests on, and link it from the clinical evaluation report and the risk management report. If the two reports describe different benefits or different residual risks, the determination has no stable basis.

Benefit-risk determination vs. risk acceptability

Risk acceptability criteria in ISO 14971 judge individual risks and the overall residual risk; the MDR's benefit-risk determination puts all of them against the clinical benefit of the device as a whole. A risk can be within the manufacturer's criteria and the benefit-risk still be unfavorable if the claimed benefit is not supported.

External references

By knowledge.aitechdoc.world · Published November 10, 2026 · Last reviewed

Source: Regulation (EU) 2017/745 on medical devices, Article 2(24), Annex I Sections 1, 4 and 8, Annex II Section 5Law in force: Binding legislation that applies as of the review date.

Definitions follow the cited standards and specifications. Where a source is a copyrighted publication, such as an ISO, IEC or EN standard, the definition is a close paraphrase, not a verbatim quotation, so as not to infringe copyright. We recommend reading the original publication. The sections “How it applies” are editorial commentary by AI TechDoc Knowledge and are not part of any standard.

Seen a mistake? Send us a note!